Chlorprothixene

DRUG2 trials

Sponsors

Hannover Medical School, Norwegian University of Science and Technology

Conditions

Anxiety DisordersDementiaDepressionObesity, MorbidPsychosomatic DisordersSchizophrenia

Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

TerminatedNCT02374567

Hannover Medical SchoolAnxiety Disorders, Dementia, Depression +2

Start: 2015-01-31End: 2017-06-28Updated: 2018-02-28

Unknown Phase

Bariatric Surgery and Pharmacokinetics of Chlorprothixene

RecruitingNCT03449485

Norwegian University of Science and TechnologyObesity, Morbid

Start: 2018-01-02End: 2026-12-31Target: 12Updated: 2025-06-08